Submitted by euronews3740 in health
Researchers used an antibody to target mutated proteins in cancer with fewer side effects than common treatments in a promising study on mice.
Submitted by euronews3740 in health
Researchers used an antibody to target mutated proteins in cancer with fewer side effects than common treatments in a promising study on mice.